Related Experiment Video
Updated: Dec 24, 2025

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
Surgical site infections after pancreaticoduodenectomy: Preoperative biliary system interventions and antimicrobial
Çağrı Bilgiç1, Şiran Keske2, Erman Sobutay1
1American Hospital, General Surgery, Istanbul, Turkey.
Background:
The rate of surgical site infection (SSI) after pancreaticoduodenectomy (PD) is high and insertion of preoperative bile duct catheterization (PBDC) predispose a high risk of SSI with multidrug resistant (MDR) microorganisms.
Aim:
To describe the effects of PBDC and the prophylaxis in development of SSI.
Methods:
We conducted a retrospective study between January 01, 2010 and December 2018 including the patients with PD and total pancreatectomy.
Findings:
In total 214 consecutive patients were included. The PBDC was inserted to 63 (29%) patients. The rate of intraoperative bile fluid culture positivity was higher among the patients with PBDC (84% vs. 17% respectively, p<0.001). The SSI was detected in 52 patients (24%). In multivariate analysis, the rate of SSI was found to be higher among the patients with PBDC (OR: 2.33, 95% Cl: 1.14-4.76, p=0.02). As the etiologic agents of SSI, Pseudomonas spp. and MDR pathogens were mainly detected in PBDC group. The resistance to ampicillin-sulbactam was significantly higher in the PBDC group (87.5% vs. 25%, p=0.012). The similar bacterial species both in bile fluid and the surgical site were detected in 11 (21%) patients with SSI. Among 8 patients (15%), antimicrobial susceptibility was the same. Only in five out of 52 (10%) patients, the SSI pathogens was susceptible to the agent that was used for surgical prophylaxis.
Conclusion:
Unnecessary catheterizations should be avoided. By considering the increasing prevalence of resistant bacteria as the cause of SSI, the clinicians should closely follow-up their patients for choosing the proper antimicrobials.
Insights
Preoperative bile duct catheterization increases surgical site infection (SSI) risk after pancreaticoduodenectomy, especially with multidrug-resistant (MDR) organisms. Avoid unnecessary procedures and monitor antimicrobial prophylaxis closely.
Area of Science:
- Gastroenterology
- Surgical Infections
- Antimicrobial Resistance
Background:
- Surgical site infection (SSI) rates are high following pancreaticoduodenectomy (PD).
- Preoperative bile duct catheterization (PBDC) is a known risk factor for SSI, often involving multidrug-resistant (MDR) microorganisms.
Purpose of the Study:
- To investigate the impact of PBDC on SSI development.
- To analyze the role of PBDC in the emergence of MDR pathogens causing SSI.
- To evaluate the effectiveness of antimicrobial prophylaxis in patients undergoing PD with PBDC.
Main Methods:
- Retrospective study of 214 patients undergoing PD or total pancreatectomy from 2010-2018.
- Comparison of SSI rates and microbial profiles between patients with and without PBDC.
- Multivariate analysis to identify risk factors for SSI.
Main Results:
- PBDC was used in 29% of patients, associated with higher intraoperative bile fluid culture positivity (84% vs. 17%).
- Overall SSI rate was 24%; PBDC significantly increased SSI risk (OR: 2.33, p=0.02).
- Pseudomonas spp. and MDR pathogens were more frequent in the PBDC group, with higher resistance to ampicillin-sulbactam (87.5% vs. 25%).
Conclusions:
- Unnecessary PBDC should be avoided to reduce SSI risk.
- Clinicians must monitor for increasing antimicrobial resistance in SSI pathogens.
- Careful selection of antimicrobial prophylaxis is crucial in PD patients, especially those with PBDC.
More Related Videos
04:31Reverse Needle Continuous Suture of the Pancreatic Duct to Jejunal Mucosal Pancreaticointestinal Anastomosis in Laparoscopic Pancreaticoduodenectomy
Published on: August 29, 2025
14:56Application of Indocyanine Green Fluorescence Imaging Technology in Laparoscopic Duodenum-Preserving Pancreatic Head Resection
Published on: November 21, 2025
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Endoscopic Procedures V: ERCP
Patient...
Peripheral Artery Disease V: Postoperative Nursing Management
Chronic Pancreatitis II: Collaborative Care
Assessment: